Thus, BAT has gained attention as a novel target for treating obesity and Type 2 diabetes due to its “fat-burning” properties (33), mediated by FGF21-FGFR1 signaling (34, 35). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.